コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ased on an archetypal cytokine receptor, the growth hormone receptor.
2 gonist and can bind only one molecule of the growth hormone receptor.
3 ed to the ligand binding determinants of the growth hormone receptor.
4 development in vitro and in vivo, as did the growth hormone receptor, a nonhematopoietic receptor.
5 ically engineered pig with a knockout of the growth hormone receptor and addition of 6 human transgen
8 n of human erythropoietin receptor and human growth hormone receptor and is supported by evidence sho
9 ed in signaling pathways found downstream of growth hormone receptor and receptor tyrosine kinases, i
11 my, or growth hormone replacement on CYP2C6, growth hormone receptor, and growth hormone-binding prot
12 ncident type 2 diabetes were aminoacylase-1, growth hormone receptor, and insulin-like growth factor-
13 lso uncommon in humans with mutations in the growth hormone receptor, and natural genetic variants in
14 0A4, S100A6, c-Myb, estrogen receptor alpha, growth hormone receptor, and progesterone receptor were
15 e regulator and rodent alpha2-macroglobulin, growth hormone receptors, and insulin-like growth factor
16 emerging somatostatin receptor ligands, the growth hormone receptor antagonist pegvisomant and the d
20 rant nature of the guinea-pig growth hormone-growth hormone receptor axis is due to these replacement
21 r cytokines, the extracellular domain of the growth hormone receptor circulates as a binding protein,
22 ons such as caloric restriction, ablation of growth hormone receptors, consumption of high-fat diets,
24 .SIGNIFICANCE STATEMENT People and mice with growth hormone receptor deficiency (GHRD or Laron syndro
28 quence were found to lead to upregulation of growth hormone receptor gene (Ghr) expression in transdu
29 The common deletion of the third exon of the growth hormone receptor gene (GHRd3) in humans is associ
37 the muscle, we specifically inactivated the growth hormone receptor (ghr) gene in postnatal mouse sk
39 vine riboprobes, expression of the IGF-I and growth hormone receptor (GHR) genes was examined in ovin
43 elopmental and tissue-specific regulation of growth hormone receptor (GHR) mRNA expression is complex
45 rtial hepatectomy by preventing increases in growth hormone receptor (GHR) via ubiquitination, suppre
47 Plasma insulin-like growth factor-1 (IGF-1), growth hormone receptor (GHR), and insulin-like growth f
50 ing group, while IGF-1-related genes [Igf1 / growth hormone receptor (Ghr)] decreased slightly (7%).
51 lication FDR-corrected p = 2.18 x 10-2), and growth hormone receptor (GHR, Discovery FDR-corrected p
52 with phosphorylated peptides from substrates growth hormone receptor (GHR-pY595) and erythropoietin r
53 disruptions in the somatotropic axis such as growth hormone receptors have an impact on DNAm maximum
54 n growth hormone (hGH) variants to the human growth hormone receptor (hGHR) and the human prolactin r
57 ve been previously noted in meningiomas (eg, growth hormone receptor, IGFBP-7, endothelin receptor A,
60 sion of growth hormone-releasing hormone and growth hormone-receptor mRNAs in the arcuate nucleus (AR
62 utated the extracellular domain of the ovine growth hormone receptor (oGHR) to the corresponding amin
65 tisera generated using peptides derived from growth hormone receptor sequences failed to recognize th
67 quired for ligand-induced endocytosis of the growth hormone receptor, suggesting that ubiquitin-depen
68 y of epitope-switching between rat and ovine growth hormone receptors to produce rat epitopes in the
70 arison of the structure to that of the human growth hormone receptor, which belongs to a different cl